RxDoctor Payments Data

Elizabeth Foret

Nurse Practitioner · Raceland, LANPI 1891792560

Payments from drug & device makers

$3,077in general payments, 2019–2025

Across 156 payments — averaging $19.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Lilly USA, LLC$388
  • AstraZeneca$335
  • Exact Sciences$228
  • Supernus Pharmaceuticals, Inc.$141
  • Pfizer$127
  • plus $849 from 18 others

What the payments were for

  • Food & beverage$3,077100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,077 in reported general payments places this provider in the 85th percentile of 969 nurse practitioner providers in Louisiana.

See all nurse practitioner providers in Louisiana

Most prescribed under Part D

DrugClaimsCost to plans & patients
MounjaroTirzepatide49$64,955
OzempicSemaglutide17$23,954
JardianceEmpagliflozin26$23,642
JanuviaSitagliptin Phosphate22$16,408
LinzessLinaclotide17$14,646
Trelegy ElliptaFluticasone/Umeclidin/Vilanter11$5,605
Lantus SolostarInsulin Glargine,hum.Rec.Anlog27$2,864
Albuterol Sulfate HfaAlbuterol Sulfate68$1,805
ValacyclovirValacyclovir Hcl19$1,707
Clonazepam146$1,527
Omeprazole47$1,126
Gabapentin94$1,108
Famotidine72$1,024
Ventolin HfaAlbuterol Sulfate17$973
Pantoprazole Sodium124$913

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCMounjaro$388$64,95549 claims
Novo NordiskOzempic$102$23,95417 claims
Boehringer IngelheimJardiance$43$23,64226 claims
AbbVieLinzess$1,009$14,64617 claims
GSKTrelegy Ellipta$28$5,60511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 969 nurse practitioner providers in Louisiana.

Other nurse practitioner in Raceland

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →